Literature DB >> 35267130

A one-pot synthesis 3-alkoxycarbonyl-3,4-dihydro-2H-pyran-2-ones from vinylidene melderum's acids, dialkyl acetylenedicarboxylates, and simple alcohols.

Samira Khandan1, Issa Yavari2, Javad Azizian1.   

Abstract

A one-pot synthesis of 3-alkoxycarbonyl-3,4-dihydro-2H-pyran-2-ones from intermolecular hetero-Diels-Alder reaction between vinylidene Melderum's acids and dialkyl acetylenedicarboxylates, in the presence of simple alcohols at room temperature, is described. The advantages of this procedure are good yields, short reaction time, and easy workup. Antioxidant properties of four derivatives of these 3,4-dihydro-2H-pyran-2-ones, together with their antimicrobial activities, are investigated.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  3-Alkoxycarbonyl-3,4-dihydro-2H-pyran-2-ones; Acetylenic ester; Antimicrobial activity; Antioxidant property; Hetero-Diels–Alder reaction; Melderum’s acid

Year:  2022        PMID: 35267130     DOI: 10.1007/s11030-022-10407-7

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  11 in total

1.  A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.

Authors:  Craig Jamieson; Stephanie Basten; Robert A Campbell; Iain A Cumming; Kevin J Gillen; Jonathan Gillespie; Bert Kazemier; Michael Kiczun; Yvonne Lamont; Amanda J Lyons; John K F Maclean; Elizabeth M Moir; John A Morrow; Marianthi Papakosta; Zoran Rankovic; Lynn Smith
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

2.  Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.

Authors:  M Walter; Y von Coburg; K Isensee; K Sander; X Ligneau; J-C Camelin; J-C Schwartz; H Stark
Journal:  Bioorg Med Chem Lett       Date:  2010-08-01       Impact factor: 2.823

3.  Cell cycle arrest and antitumor activity of pironetin and its derivatives.

Authors:  M Kondoh; T Usui; S Kobayashi; K Tsuchiya; K Nishikawa; T Nishikiori; T Mayumi; H Osada
Journal:  Cancer Lett       Date:  1998-04-10       Impact factor: 8.679

Review 4.  A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.

Authors:  Piyush N Kalaria; Sharad C Karad; Dipak K Raval
Journal:  Eur J Med Chem       Date:  2018-08-19       Impact factor: 6.514

Review 5.  Hybrid Bioactive Heterocycles as Potential Antimicrobial Agents: A Review.

Authors:  Nisheeth Desai; Amit Trivedi; Unnat Pandit; Amit Dodiya; V Kameswara Rao; Priyanka Desai
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

6.  Three-component synthesis of functionalized 5-oxo-4,5-dihydroindeno[1,2-b]pyrans.

Authors:  Issa Yavari; Mehdi Sirouspour; Sanaz Souri
Journal:  Mol Divers       Date:  2006-06-16       Impact factor: 2.943

7.  Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class.

Authors:  S R Turner; J W Strohbach; R A Tommasi; P A Aristoff; P D Johnson; H I Skulnick; L A Dolak; E P Seest; P K Tomich; M J Bohanon; M M Horng; J C Lynn; K T Chong; R R Hinshaw; K D Watenpaugh; M N Janakiraman; S Thaisrivongs
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

8.  Reverse orientation in the ultrasound-assisted [3 + 2]-cycloaddition reaction of nitrile imines with 3-formylchromone-Meldrum's acid adducts.

Authors:  Issa Yavari; Younes Fadakar
Journal:  Mol Divers       Date:  2021-06-15       Impact factor: 2.943

9.  Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study.

Authors:  Francisco M Marty; Choy Y Man; Charles van der Horst; Bruno Francois; Denis Garot; Rafael Mánez; Visanu Thamlikitkul; José A Lorente; Francisco Alvarez-Lerma; David Brealey; Henry H Zhao; Steve Weller; Phillip J Yates; Amanda F Peppercorn
Journal:  J Infect Dis       Date:  2013-08-27       Impact factor: 5.226

Review 10.  Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine's Tool Box.

Authors:  Pedro Martins; João Jesus; Sofia Santos; Luis R Raposo; Catarina Roma-Rodrigues; Pedro Viana Baptista; Alexandra R Fernandes
Journal:  Molecules       Date:  2015-09-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.